FindTrial
Sign In

The role and mechanisms of HIF-2a in non-small cell lung driven by chronic obstructive pulmonary disease

The role and mechanisms of HIF-2a in non-small cell lung driven by chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057045
Enrollment
Unknown
Registered
2022-02-26
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC, COPD

Interventions

None listed

Sponsors

Shenzhen Baoan District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with non-small cell lung cancer conformed to the Chinese Standard for the Treatment of Primary Lung Cancer, and postoperative pathological specimens were confirmed as non-small cell lung cancer; 2. Preoperative pulmonary function results were available, and FEV1/FVC 40 years old, meeting ethical standards, and all subjects participated voluntarily and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with asthma; 2. Patients with mental disorders or cognitive dysfunction; 3. Associated with other malignant tumors or those with a history of malignant tumors; 4. Pregnant or breastfeeding women; 5. Those who are deemed unsuitable for inclusion by the investigator.

Design outcomes

Primary

MeasureTime frame
HIF2a;—

Secondary

MeasureTime frame
NSCLC TNM;Pulmonary fuction test;Survival time;—

Countries

China

Contacts

Public ContactLizhi Huang

Shenzhen Baoan District People's Hospital

forrege2@126.com+86 17137623715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026